MXJVX
Price
$10.65
Change
+$0.16 (+1.53%)
Updated
Aug 22 closing price
Net Assets
1.46B
VTISX
Price
$162.01
Change
-$1.46 (-0.89%)
Updated
Aug 25 closing price
Net Assets
505.75B
Interact to see
Advertisement

MXJVX vs VTISX

Header iconMXJVX vs VTISX Comparison
Open Charts MXJVX vs VTISXBanner chart's image
Empower International Value Instl
Price$10.65
Change+$0.16 (+1.53%)
VolumeN/A
Net Assets1.46B
Vanguard Total Intl Stock Idx Instl Sel
Price$162.01
Change-$1.46 (-0.89%)
VolumeN/A
Net Assets505.75B
MXJVX vs VTISX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MXJVX vs. VTISX commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXJVX is a Buy and VTISX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTISX has more cash in the bank: 506B vs. MXJVX (1.46B). VTISX pays higher dividends than MXJVX: VTISX (2.87) vs MXJVX (2.71). MXJVX was incepted earlier than VTISX: MXJVX (10 years) vs VTISX (9 years). MXJVX (0.71) is less costly to investors than VTISX (0.05). MXJVX is a more actively managed with annual turnover of: 25.00 vs. VTISX (3.00). MXJVX has a lower initial minimum investment than VTISX: MXJVX (0) vs VTISX (3000000000). MXJVX annual gain was more profitable for investors over the last year : 19.30 vs. VTISX (15.09). MXJVX return over 5 years is better than : 50.89 vs. VTISX (39.34).
MXJVXVTISXMXJVX / VTISX
Total Expense Ratio0.710.051,511%
Annual Report Gross Expense Ratio0.710.051,511%
Fund Existence10 years9 years-
Gain YTD30.99622.804136%
Front LoadN/AN/A-
Min. Initial Investment03000000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.46B506B0%
Annual Yield % from dividends2.712.8794%
Returns for 1 year19.3015.09128%
Returns for 3 years54.3442.90127%
Returns for 5 years50.8939.34129%
Returns for 10 years46.06N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PMCB1.020.05
+5.66%
PharmaCyte Biotech
RAPP14.63-0.14
-0.95%
Rapport Therapeutics Inc.
GMAB24.31-0.34
-1.38%
Genmab A/S ADS
PAYO6.78-0.23
-3.28%
Payoneer Global
CSBR7.06-0.57
-7.47%
Champions Oncology